The SARS-CoV-2 infection has caused mortality in different populations; in addition, morbidity withimmunological, hematological and/or cardiovascular compromises has been reported, with acutemyocardial infarction (AMI) standing out. A literature search was conducted in databases todetermine existing evidence regarding AMI in post-COVID-19 patients. It was found that initially AMIwas described in some patients during the disease; however, a recently published case seriesshowed that it could occur in recovered patients, secondary to systemic and procoagulantinflammation over time, suggesting further research in this area.